Work

Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.

Year: 2005

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Niklas Zojer, Karin Brenner, Dora Beke, Stefan Kudlacek, Gerhard Hawa, Wolfgang Woloszczuk, Lorenz C Hofbauer, Martin Pecherstorfer

Institution: Wilhelminen Hospital

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2342261464

FWCI: 0.172

Cites: 25

Cited by: 10

Related to: 10